NCT03827811 (PandrTB) is a clinical trial in Multi-drug Resistant Tuberculosis, sponsored by University of Cape Town.

Who is sponsoring NCT03827811?

NCT03827811 is sponsored by University of Cape Town.

What condition does NCT03827811 study?

NCT03827811 studies Multi-drug Resistant Tuberculosis.

Is NCT03827811 still recruiting?

NCT03827811 is currently status unknown. Last updated 4 November 2022.

Last reviewed 2022-11-04 · How we verify

NCT03827811: PandrTB

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Pharmacometrics to Advance Novel Regimens for Drug-resistant Tuberculosis-PandrTB Tuberculosis

Status unknown Last updated 4 November 2022

What this trial tests

trial in Multi-drug Resistant Tuberculosis in 625 participants. Status unknown.

Timeline

30 January 2020

Primary endpoint
30 April 2023

30 April 2023

Quick facts

Lead sponsor	University of Cape Town
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	625
Start date	30 January 2020
Primary completion	30 April 2023
Estimated completion	30 April 2023
Sites	7 locations across Pakistan, South Africa, Peru, Kazakhstan, Vietnam, Lesotho

Conditions studied

Multi-drug Resistant Tuberculosis — all drugs for Multi-drug Resistant Tuberculosis →

Sponsor

University of Cape Town

Who can join

Adults 15 to 99, any sex, with Multi-drug Resistant Tuberculosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

PandrTB is a study of the pharmacokinetics(PK) and pharmacodynamics(PD) of bedaquiline, delamanid, clofazimine, linezolid, moxifloxacin, levofloxacin and pyrazinamide used in novel combinations to treat multidrug-resistant tuberculosis(MDR-TB).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other University of Cape Town trials

Trials by the same sponsor.

NCT06997328 — '5 Rs to Rescue' A Cluster Trial With an Embedded Process Evaluation · recruiting
NCT06431321 — Evaluation of a 2-session Parent Training Programme for Caregivers of Younger Children in Zimbabwe · NA · not yet recruiting
NCT06051526 — The African Critical Illness Outcomes Study · completed
NCT05723484 — Comparing a Novel Point-of-care Cytokine Biomarker Lateral Flow Test With Nucleic Acid Amplification Tests for Detection · completed
NCT05681871 — South African Paediatric Surgical Outcomes Study 2 · Phase 4 · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03827811 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Cape Town
Last refreshed: 4 November 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03827811.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing